Jacobio Pharmaceuticals Co., Ltd.

This study tests an experimental drug called JAB-2485 in adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 102 participants will take part in two phases: first to check sa…

This study tests an experimental drug called JAB-30355 in adults with advanced solid tumors that have a specific TP53 Y220C mutation. The main goals are to check safety and find the right dose, while also seeing if the drug can shrink tumors. About 144 participants who have alrea…

This early-stage trial tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung, ovarian, or esophageal cancer) or blood cancers (like leukemia). The goal is to find a safe dose and see if it can shrink tumors. About 152 people whose cancer has worsened af…

This study tests a new drug called JAB-23E73 in adults with advanced solid tumors that have a specific genetic change (KRAS alteration). The main goals are to find safe doses and check for early signs that the drug can shrink tumors. About 294 participants will take part in this …